Which drug eases pain better after sleeve gastrectomy?
NCT ID NCT07327905
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests two drugs—lidocaine and dexmedetomidine—given as infusions during laparoscopic sleeve gastrectomy to see which one helps with pain and recovery. Forty adults aged 20-50 with a BMI of 35-50 are being recruited. The goal is to find a better way to manage early post-surgery pain and reduce complications like nausea.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- lidocaine and dexmedetomidine
- What this could lead to
- If one drug works better, it could lead to a standard way to manage pain after weight-loss surgery, helping patients recover more comfortably.
- What could go wrong
- This is a small, early-stage trial with only 40 people, so results may not apply to everyone. Both drugs have side effects like nausea or low blood pressure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BARIATRIC SURGERY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Alexandria University
RECRUITINGAlexandria, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?